Kyttaro
Pre-clinicalA German biotech company developing targeted protein degradation therapies for oncology and other diseases.
Founded
2020
Focus
AntibodiesBiologics
About
A German biotech company developing targeted protein degradation therapies for oncology and other diseases.
Company Info
TypePrivate
Founded2020
LocationMunich, Germany
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile